Showing results (201-210 of 253) with videos related to
Sort By:
Pageof 26
Frontiers in Immunology|December 27, 2021
NFAT5 Controls the Integrity of EpidermisKhalid Muhammad, Delicia Xavier, Stefan Klein-Hessling, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.Oncogene|September 26, 2020
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expressionChristina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.Cancers|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood NeutrophilsSimone Wendlinger, Jonas Wohlfarth, Claudia Siedel, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 10, 2019
Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differencesMoritz Felcht, Claus-Detlev Klemke, Jan Peter Nicolay, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 3, 2024
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patientsInga Hansen-Abeck, Glenn Geidel, Finn Abeck, et al.International Journal of Molecular Sciences|August 14, 2025
Influence of a Th17-Inducing Cytokine Milieu on Phenotypical and Functional Properties of Regulatory T Cells in Chronic Inflammatory ArthritisTobias Schwarz, Giovanni Almanzar, Marie Wulfheide, et al.The Journal of Investigative Dermatology|September 4, 2021
Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine DifferentiationThibault Kervarrec, Silke Appenzeller, Mahtab Samimi, et al.Cancer|December 19, 2018
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomasSilke Appenzeller, Anja Gesierich, Alexander Thiem, et al.Pageof 26